In non-small cell lung cancer, FCGBP exhibits the highest mutation frequency among smoking-related genes, with its downregulation strongly correlating with enhanced tumor proliferation, migration, and immunosuppressive microenvironments in smokers [46]. This evidence concerns the gene FCGBP and neoplasm.